PATENT CLAIM ANALYSIS

Application Number: 15868201
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["506", "009000"]

Abstract:
The present invention relates to the identification of chemokine biomarkers predictive of future acute coronary syndromes including unstable angina pectoris (UAP). The present invention also identifies particular chemokines as potential therapeutic targets for intervention in cardiovascular diseases.

Claim (Index 6):
The method according to  claim 1 , wherein the amount of compound bound to an antibody is detected by a method selected from the group consisting of an immunoassay, an enzyme linked immunoassay (ELISA), a fluorescence based assay, a dissociation enhanced lanthanide fluoroimmunoassay (DELFIA), a radiometric assay, a multiplex immunoassay, and a cytometric bead assay (CBA).

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.13889
- Patent Class: 506.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12677437', '14388164', '15128560', '15171713', '13575354']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6671532856000523
- 35 USC 102 Novelty (BERT): 0.6660716686696045
- Combined Prediction Score: 0.6670451239070075
- Mean Citation Score: 379.722638
- Max Citation Score: 647.8530000000002
- Similarity Product: 643.1607310656311

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test